Gene, the British alternative rock band that defined mid-1990s Britpop alongside Blur and Oasis, returns to North America this November for their first tour of the continent in nearly a quarter-century. The Sheffield four-piece will play select dates across the US and Canada, marking a significant reunion for the group that disbanded in 2004 before reforming in 2018.
The tour represents a major moment for a band whose cultural footprint has only grown since their initial breakup. Gene's 1995 debut "Olympian" and 1996 follow-up "Drawn to the Deep End" captured the swagger and melodic ambition of Britpop's golden age, with frontman Martin Rossiter's soaring vocals and the band's shimmering guitar work positioning them as serious contenders alongside their more celebrated contemporaries. Though they never achieved the commercial dominance of Blur or Oasis in either the UK or US markets, Gene built a devoted cult following that sustained their legacy through the intervening years.
The 24-year gap since their last North American appearances underscores how thoroughly the touring landscape has shifted. When Gene originally disbanded, streaming services and social media did not exist. Their reunion in 2018 came during a broader Britpop nostalgia wave that has only intensified, with festivals and promoters recognizing the enduring appetite for 90s alternative rock. The band returned with a 2020 EP before embarking on UK and European dates in recent years.
For longtime fans who may have only experienced Gene through grainy MTV Europe performances and bootleg recordings, the November dates offer a rare opportunity to see the band live. North American audiences who missed the band's original moment now have a chance to witness Britpop history firsthand. Gene's announcement taps into the same resurgence that has revitalized careers of peers like Pulp and Suede, proving that guitar-driven rock from this era retains considerable commercial viability and emotional resonance.